Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial
1. 系统已在2025-09-22 11:06:57对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s40259-024-00668-z
文献链接: https://link.springer.com/10.1007/s40259-024-00668-z
其他信息:
出版社: Springer Science and Business Media LLC
作者: Yan Zhao; Jing-Yi Li; Bin Yang; Yang-Feng Ding; Li-Ming Wu; Li-Tao Zhang; Jin-Yan Wang; Qian-Jin Lu; Chun-Lei Zhang; Fu-Ren Zhang; Xiao-Hong Zhu; Yu-Mei Li; Xiao-Hua Tao; Qing-Chun Diao; Lin-Feng Li; Jian-Yun Lu; Xiao-Yong Man; Fu-Qiu Li; Xiu-Juan Xia; Jiao-Ran Song; Ying-Min Jia; Li-Bo Zhang; Bo Chen; Jian-Zhong Zhang
全文下载地址: https://link.springer.com/content/pdf/10.1007/s40259-024-00668-z.pdf
